AC
Ayrton Capital LLC cut its APVO stake below 5%
Ayrton Capital LLC reported owning 3.7% of Aptevo Therapeutics Inc. (APVO) (69,965 shares) in a Schedule 13G filed Nov 12, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 12, 2026
- Source
- Schedule 13G